The effect of CYP 2D6 genotype and CYP2D6 inhibitors on tamoxifen

被引：0
|
作者：
Stearns, V
Hayes, DF
Jin, Y
Ullmer, L
Nguyen, A
Storniolo, AM
Flockhart, U
Desta, Z
机构：
[1] Johns Hopkins Sch Med, Baltimore, MD USA
[2] Univ Michigan, Ann Arbor, MI 48109 USA
[3] Indiana Univ, Sch Med, Indianapolis, IN 46204 USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2004年 / 22卷 / 14期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
508
引用
收藏
页码：5S / 5S
页数：1
相关论文
共 50 条
  • [1] CYP2D6 genotype and tamoxifen response
    James M Rae
    Matthew P Goetz
    Daniel F Hayes
    James N Ingle
    Lang Li
    Anna Maria Storniolo
    Vered Stearns
    David A Flockhart
    [J]. Breast Cancer Research, 7
  • [2] CYP2D6 Genotype and Adjuvant Tamoxifen
    Berry, D. A.
    [J]. CLINICAL PHARMACOLOGY & THERAPEUTICS, 2014, 96 (02) : 138 - 140
  • [3] CYP2D6 genotype and tamoxifen response
    Rae, JM
    Goetz, MP
    Hayes, DF
    Ingle, JN
    Li, L
    Storniolo, AM
    Stearns, V
    Flockhart, DA
    [J]. BREAST CANCER RESEARCH, 2005, 7 (05)
  • [4] Response to CYP2D6 substrate antidepressants is predicted by a CYP2D6 composite phenotype based on genotype and comedications with CYP2D6 inhibitors
    Gressier, F.
    Verstuyft, C.
    Hardy, P.
    Becquemont, L.
    Corruble, E.
    [J]. JOURNAL OF NEURAL TRANSMISSION, 2015, 122 (01) : 35 - 42
  • [5] Is CYP2D6 phenotype predictable from CYP2D6 genotype?
    Kiss, Adam Ferenc
    Toth, Katalin
    Juhasz, Cintia
    Temesvari, Manna
    Paulik, Jozsef
    Hirka, Gabor
    Monostory, Katalin
    [J]. MICROCHEMICAL JOURNAL, 2018, 136 : 209 - 214
  • [6] Response to CYP2D6 substrate antidepressants is predicted by a CYP2D6 composite phenotype based on genotype and comedications with CYP2D6 inhibitors
    F. Gressier
    C. Verstuyft
    P. Hardy
    L. Becquemont
    E. Corruble
    [J]. Journal of Neural Transmission, 2015, 122 : 35 - 42
  • [7] Quantitative assessment of the effect of CYP2D6 genotype on tamoxifen metabolism: A model for CYP2D6 genotype-phenotype studies.
    Borges, S
    Desta, Z
    Jin, Y
    Li, L
    Skaar, TC
    Flockhart, DA
    [J]. CLINICAL PHARMACOLOGY & THERAPEUTICS, 2006, 79 (02) : P34 - P34
  • [8] IN VITRO COMPARATIVE INHIBITORY PROFILES OF SEVERAL CYP2D6 INHIBITORS AND METABOLIC CAPABILITIES OF CYP2D6*1, CYP2D6*2, CYP2D6*10, AND CYP2D6*17 ON TRAMADOL METABOLISM
    Nahid, N.
    Kanumuri, S.
    Sharma, A.
    Wang, D.
    Johnson, J.
    [J]. CLINICAL PHARMACOLOGY & THERAPEUTICS, 2024, 115 : S74 - S75
  • [9] Avoidance of CYP2D6 Inhibitors in Patients Receiving Tamoxifen
    Ferraldeschi, Roberta
    Howell, Sacha J.
    Thompson, Alastair M.
    Newman, William G.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2010, 28 (29) : E584 - E585
  • [10] Should CYP2D6 inhibitors be administered in conjunction with tamoxifen?
    Zembutsu, Hitoshi
    Sasa, Mitsunori
    Kiyotani, Kazuma
    Mushiroda, Taisei
    Nakamura, Yusuke
    [J]. EXPERT REVIEW OF ANTICANCER THERAPY, 2011, 11 (02) : 185 - 193
12345